Clinical Trials Arena on MSN
Kamada enrols first subject in Cytogam trial for CMV infection
The controlled multi-centre, randomised, prospective trial is investigating the therapy in kidney transplant recipients.
Kamada begins patient enrolment in an investigator-initiated clinical trial of Cytogam to prevent cytomegalovirus in kidney transplantation: Rehovot, Israel Thursday, November 6, ...
The study, titled “ Strategic Help with Immunoglobulin to Enhance protection against Late Disease (CMV) ” or SHIELD, is a prospective, randomized, controlled multicenter investigator-initiated study ...
Enhancing continuous manufacturing of vaccines, researchers innovate a Raman spectroscopy tool for efficient quality control in production.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback